Aminocaproic acid
Country of origin: Belarus, Biomed named after Mechnikov Russia, Dalkhimfarm Russia, Kraspharma Russia, Moskhimfarmpreparaty named after. ON THE. Semashko Russia, Polysintez Russia, Pharmakon Russia, Khabarovsk State Enterprise for the production of bacterial preparations Russia, Khimtekhnologiya GOSNIPI chemical technologies U
Pharm-Group: Fibrinolysis inhibitors
Manufacturers: Belmedpreparaty (Belarus), Biomed named after Mechnikov (Russia), Dalkhimfarm (Russia), Kraspharma (Russia), Moskhimfarmpreparaty named after. ON THE. Semashko (Russia), Polysintez (Russia), Pharmakon (Russia), Khabarovsk State Enterprise for the production of bacterial preparations (Russia), Khimtekhnologiya GOSNIPI
International name: Aminocaproic acid
Dosage forms: substance 0.5 kg, solution for injection 5%, granules for children, substance 1 kg, solution for infusion 5%, substance, substance 50 g, substance 200 g, substance 5 kg, substance-powder, substance 1 g
Composition: Active ingredient - aminocaproic acid.
Indications for use: Conditions with increased fibrinolytic activity of the blood in cardiac and vascular surgery, during surgical interventions for neoplastic processes in the lungs, prostate gland, stomach, thyroid gland, cervix, with massive blood transfusions.
Contraindications: Hypercoagulable states with a tendency to thrombus formation and embolism, impaired renal function, cerebrovascular accidents, bleeding from the upper urinary tract of unknown etiology, disseminated intravascular coagulation syndrome, pregnancy.
Side effects: Rhabdomyolysis, myoglobinuria, headache, dizziness, tinnitus, nasal congestion, acute renal failure, subendocardial hemorrhage, nausea, diarrhea, convulsions, hypotension, skin rashes.
Interaction: The effect is reduced by anticoagulants and antiplatelet agents.
Overdose: No data available.
Special instructions: No data available.
Literature: Encyclopedia of Medicines 2003, Encyclopedia of Medicines 2004.